Compare BHST & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BHST | OXSQ |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.1M | 151.1M |
| IPO Year | N/A | N/A |
| Metric | BHST | OXSQ |
|---|---|---|
| Price | $5.30 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 61.8K | ★ 856.4K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 23.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $32,720,000.00 | ★ $40,142,565.00 |
| Revenue This Year | $116.40 | N/A |
| Revenue Next Year | $55.91 | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 45.88 | N/A |
| 52 Week Low | $4.72 | $1.56 |
| 52 Week High | $12.80 | $2.87 |
| Indicator | BHST | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 40.33 |
| Support Level | $5.07 | $1.72 |
| Resistance Level | $5.43 | $1.78 |
| Average True Range (ATR) | 0.43 | 0.04 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 23.36 | 22.22 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.